Valion Bio (VBIO) Market Capitalization (2021 - 2026)

Valion Bio has reported Market Capitalization for 6 years, with the latest figure at $70304.0 in Q2 2026.

• On a quarterly basis, Market Capitalization fell 56.15% year-over-year to $70304.0 in Q2 2026; TTM through Jun 2026 was $70304.0, a 56.15% decrease from a year earlier, with the FY2025 full-year figure at $67020.5, down 0.93% from the prior year.
• Market Capitalization was $70304.0 for Q2 2026 at Valion Bio, up from $67020.5 in the prior quarter.
• The five-year high for Market Capitalization was $1.3 billion in Q2 2022, with the low at $67020.5 in Q4 2025.
• Average Market Capitalization over 5 years is $139.0 million, with a median of $1.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization slumped 99.83% in 2023, then retreated 0.93% in 2025.
• Over 5 years, Market Capitalization stood at $4.2 million in 2022, then slumped by 76.95% to $970693.2 in 2023, then tumbled by 93.03% to $67648.1 in 2024, then slipped by 0.93% to $67020.5 in 2025, then gained by 4.9% to $70304.0 in 2026.
• The last three Market Capitalization figures came in at $70304.0 (Q2 2026), $67020.5 (Q4 2025), and $152681.6 (Q3 2025), per Business Quant data.